Home / BusinessBusinessCNBCBusinessCNBC·Sep 14, 2026·1 min readNovo Nordisk rebrands to 'Novo,' unveils corporate changes as it fights for obesity market shareThe Danish drugmaker called the changes the beginning of a new chapter for the company, which faces stiff competition from Eli Lilly.View original source — CNBC ↗ShareCopy linkShare on XShare on FacebookRelated storiesBusinessBloombergBusinessSep 4, 2026 · 1 minNovo Owner to Build $62 Million Quantum Chip Plant in DenmarkBloombergWorldSouth China Morning PostWorldJun 7, 2026 · 1 minWhich company could become the Chinese Pfizer? Here are analysts’ top picksSouth China Morning PostHealthFinancial TimesHealthJun 8, 2026 · 1 minAstraZeneca advances weight-loss pill to take aim at obesity leadersFinancial TimesTechnologyThe Next WebTechnologySep 4, 2026 · 1 minNovo Nordisk Foundation to build $62M quantum chip plant in CopenhagenThe Next Web
BusinessBloombergBusinessSep 4, 2026 · 1 minNovo Owner to Build $62 Million Quantum Chip Plant in DenmarkBloomberg
WorldSouth China Morning PostWorldJun 7, 2026 · 1 minWhich company could become the Chinese Pfizer? Here are analysts’ top picksSouth China Morning Post
HealthFinancial TimesHealthJun 8, 2026 · 1 minAstraZeneca advances weight-loss pill to take aim at obesity leadersFinancial Times
TechnologyThe Next WebTechnologySep 4, 2026 · 1 minNovo Nordisk Foundation to build $62M quantum chip plant in CopenhagenThe Next Web